Loading Events

« All Events

  • This event has passed.

Cell & Gene Therapy Manufacturing Virtual Conference

October 28 - October 29

Cell & Gene Therapy Manufacturing Virtual Conference

3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference – Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. There are still factors like manufacturing maze, investment, logistics, and regulatory challenges which prevent the cell and gene therapies from being widely used. We are again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges at our 3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference. Virtual; Oct 28-29, 2021


We are pleased to announce that we have partnered with MarketsandMarkets to offer our readers an exclusive discount of 30% when they register. Use discount coupon code: “MMTWIDH30” when registering.


Key Highlights

  • Cell culture through the dimensional process
  • Lentiviral bioprocessing
  • Automation of cellular therapies
  • AAV vector production
  • Process development and monitoring of cell-gene therapies
  • CMC considerations for NK cells
  • Supply chain and regulatory issues

Who Should attend

From Therapeutics and Pharmaceuticals, Cell & Gene therapy-based companies: Engineers/Scientists/Researchers/Project leaders in Bioprocess development, Process development, GMP/Manufacturing, Cellular Therapy, Gene Therapy, Quality Control, Cell Engineering, Regulatory affairs.

From Universities and Research Institutes: Scientists/Professors/Researchers/Project leaders in Bioprocessing, Bioengineering, Biomaterials, Chemical Engineering, Material Sciences, Cell therapy, Gene therapy, Cell culture, Cell Engineering, GMP/Manufacturing


MarketsandMarkets™ is the world’s largest revenue impact company, serving over 10,000 customers, including 80% of Forbes Global 2000 B2B companies in the industries that we track. In the face of constant technology innovation and market disruption, we help organizations plan & operationalize their future revenue mix decisions by identifying over 30,000 high-growth opportunities ranging from $1B to $500B. Our revenue impact methodology provides actionable & quantified insights on converged, granular, and networked market ecosystems that result from disruptive technologies and high-growth markets. We offer an extended lens on what will impact our client’s revenue and what will impact their clients’​ revenues, thus uncovering latent opportunities. OrAs a result, organizations choose MarketsandMarkets™ to stay ahead of the curve and accelerate their hot-bet revenue decisions and implementations by 6 – 12 months, giving them a unique fast-mover innovation advantage. We work across all major B2B industries with the C-level executives in functions such as Strategy, Marketing, Sales, R&D, Product, M&A, etc.

MarketsandMarkets™ brings exclusive high-growth markets intelligence generated by over 850 SMEs and analysts along with its proprietary Revenue Impact platform, Knowledge Store, to support decision making. Over 70% of our intelligence is exclusive, and we advise our clients on areas such as – What revenues can you expect from newer innovations? Where are the explicit and latent opportunities, markets, technologies, products, and use cases? What is the opportunity for your client in $ terms by adopting your new products and offerings?. In addition, our engagement model ensures ongoing contextual deep-dives and operationalization of revenue impact decisions. For more information, please visit www.marketsandmarkets.com.

Cell & Gene Therapy Manufacturing Virtual Conference

Digital Health Events – Oct to Dec 2021 -Healthcare Conference